0.008797 0.000000 0.000456 0.000000 0.014426 0.000000 0.000000 0.000000 0.023633 0.00000 0.00000 0.00000 Griessner, A. Brandstetter, H. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic 8 90.00 92.97 90.00 113.670 69.320 42.370 C2 H4 O 44.053 ACETYL GROUP non-polymer C4 H9 N O2 103.120 n ALPHA-AMINOISOBUTYRIC ACID L-peptide linking C3 H7 N O2 89.093 y ALANINE L-peptide linking C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C3 H7 N O2 S 121.158 y CYSTEINE L-peptide linking C5 H10 N2 O3 146.144 y GLUTAMINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C3 H8 O3 92.094 GLYCEROL GLYCERIN; PROPANE-1,2,3-TRIOL non-polymer C6 H10 N3 O2 1 156.162 y HISTIDINE L-peptide linking H2 O 18.015 WATER non-polymer C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C5 H11 N O2 S 149.211 y METHIONINE L-peptide linking C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking C5 H9 N O2 115.130 y PROLINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C4 H9 N O3 119.119 y THREONINE L-peptide linking C9 H11 N O3 181.189 y TYROSINE L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking US J.Biol.Chem. JBCHA3 0071 0021-9258 289 1732 10.1074/JBC.M113.533836 24275667 Small Peptides Blocking Inhibition of Factor Xa and Tissue Factor-Factor Viia by Tissue Factor Pathway Inhibitor (Tfpi) 2014 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 100 1 SINGLE WAVELENGTH M x-ray 1 0.97 1.0 X12 EMBL/DESY, HAMBURG 0.97 SYNCHROTRON EMBL/DESY, HAMBURG BEAMLINE X12 9278.473 TISSUE FACTOR PATHWAY INHIBITOR (LIPOPROTEIN-ASSOCIATED COAGULATION INHIBITOR) VARIANT RESIDUES 40-118 2 nat polymer 2363.712 PEPTIDE 2 syn polymer 92.094 GLYCEROL 2 syn non-polymer 18.015 water 72 nat water no no DSEEDEEHTIITDTELPPLKLMHSFCAFKADDGPCKAIMKRFFFNIFTRQCEEFIYGGCEGNQNRFESLEECKKMCTRD DSEEDEEHTIITDTELPPLKLMHSFCAFKADDGPCKAIMKRFFFNIFTRQCEEFIYGGCEGNQNRFESLEECKKMCTRD A,B polypeptide(L) no yes (ACE)FQSKPNVHVDGYFERL(AIB)AKL XFQSKPNVHVDGYFERLAAKL C,D polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n HUMAN sample 9606 HOMO SAPIENS 3.58 65.68 NONE diffrn_source pdbx_unobs_or_zero_occ_residues struct_conn repository Initial release Database references Database references Database references Advisory Data collection Derived calculations 1 0 2013-12-04 1 1 2013-12-11 1 2 2014-02-05 1 3 2015-03-25 1 4 2019-07-17 _diffrn_source.pdbx_synchrotron_site _struct_conn.pdbx_leaving_atom_flag PDBE Y PDBE 2013-05-30 REL 1 A O HOH 2006 5.95 1 B O HOH 2026 7.23 GOL GLYCEROL HOH water 32630 SYNTHETIC CONSTRUCT sample GOL 1080 3 GOL GOL 1080 B GOL 1081 3 GOL GOL 1081 B HOH 2001 4 HOH HOH 2001 A HOH 2002 4 HOH HOH 2002 A HOH 2003 4 HOH HOH 2003 A HOH 2004 4 HOH HOH 2004 A HOH 2005 4 HOH HOH 2005 A HOH 2006 4 HOH HOH 2006 A HOH 2007 4 HOH HOH 2007 A HOH 2008 4 HOH HOH 2008 A HOH 2009 4 HOH HOH 2009 A HOH 2010 4 HOH HOH 2010 A HOH 2011 4 HOH HOH 2011 A HOH 2012 4 HOH HOH 2012 A HOH 2013 4 HOH HOH 2013 A HOH 2014 4 HOH HOH 2014 A HOH 2015 4 HOH HOH 2015 A HOH 2016 4 HOH HOH 2016 A HOH 2017 4 HOH HOH 2017 A HOH 2018 4 HOH HOH 2018 A HOH 2019 4 HOH HOH 2019 A HOH 2020 4 HOH HOH 2020 A HOH 2021 4 HOH HOH 2021 A HOH 2022 4 HOH HOH 2022 A HOH 2023 4 HOH HOH 2023 A HOH 2024 4 HOH HOH 2024 A HOH 2025 4 HOH HOH 2025 A HOH 2026 4 HOH HOH 2026 A HOH 2027 4 HOH HOH 2027 A HOH 2028 4 HOH HOH 2028 A HOH 2029 4 HOH HOH 2029 A HOH 2030 4 HOH HOH 2030 A HOH 2031 4 HOH HOH 2031 A HOH 2032 4 HOH HOH 2032 A HOH 2033 4 HOH HOH 2033 A HOH 2001 4 HOH HOH 2001 B HOH 2002 4 HOH HOH 2002 B HOH 2003 4 HOH HOH 2003 B HOH 2004 4 HOH HOH 2004 B HOH 2005 4 HOH HOH 2005 B HOH 2006 4 HOH HOH 2006 B HOH 2007 4 HOH HOH 2007 B HOH 2008 4 HOH HOH 2008 B HOH 2009 4 HOH HOH 2009 B HOH 2010 4 HOH HOH 2010 B HOH 2011 4 HOH HOH 2011 B HOH 2012 4 HOH HOH 2012 B HOH 2013 4 HOH HOH 2013 B HOH 2014 4 HOH HOH 2014 B HOH 2015 4 HOH HOH 2015 B HOH 2016 4 HOH HOH 2016 B HOH 2017 4 HOH HOH 2017 B HOH 2018 4 HOH HOH 2018 B HOH 2019 4 HOH HOH 2019 B HOH 2020 4 HOH HOH 2020 B HOH 2021 4 HOH HOH 2021 B HOH 2022 4 HOH HOH 2022 B HOH 2023 4 HOH HOH 2023 B HOH 2024 4 HOH HOH 2024 B HOH 2025 4 HOH HOH 2025 B HOH 2026 4 HOH HOH 2026 B HOH 2001 4 HOH HOH 2001 C HOH 2002 4 HOH HOH 2002 C HOH 2003 4 HOH HOH 2003 C HOH 2004 4 HOH HOH 2004 C HOH 2005 4 HOH HOH 2005 C HOH 2006 4 HOH HOH 2006 C HOH 2007 4 HOH HOH 2007 C HOH 2008 4 HOH HOH 2008 C HOH 2001 4 HOH HOH 2001 D HOH 2002 4 HOH HOH 2002 D HOH 2003 4 HOH HOH 2003 D HOH 2004 4 HOH HOH 2004 D HOH 2005 4 HOH HOH 2005 D n 1 1 A SER 2 n 2 SER 2 A GLU 3 n 3 GLU 3 A GLU 4 n 4 GLU 4 A ASP 5 n 5 ASP 5 A GLU 6 n 6 GLU 6 A GLU 7 n 7 GLU 7 A HIS 8 n 8 HIS 8 A THR 9 n 9 THR 9 A ILE 10 n 10 ILE 10 A ILE 11 n 11 ILE 11 A THR 12 n 12 THR 12 A ASP 13 n 13 ASP 13 A THR 14 n 14 THR 14 A GLU 15 n 15 GLU 15 A LEU 16 n 16 LEU 16 A PRO 17 n 17 PRO 17 A PRO 18 n 18 PRO 18 A LEU 19 n 19 LEU 19 A LYS 20 n 20 LYS 20 A LEU 21 n 21 LEU 21 A MET 22 n 22 MET 22 A HIS 23 n 23 HIS 23 A SER 24 n 24 SER 24 A PHE 25 n 25 PHE 25 A CYS 26 n 26 CYS 26 A ALA 27 n 27 ALA 27 A PHE 28 n 28 PHE 28 A LYS 29 n 29 LYS 29 A ALA 30 n 30 ALA 30 A ASP 31 n 31 ASP 31 A ASP 32 n 32 ASP 32 A GLY 33 n 33 GLY 33 A PRO 34 n 34 PRO 34 A CYS 35 n 35 CYS 35 A LYS 36 n 36 LYS 36 A ALA 37 n 37 ALA 37 A ILE 38 n 38 ILE 38 A MET 39 n 39 MET 39 A LYS 40 n 40 LYS 40 A ARG 41 n 41 ARG 41 A PHE 42 n 42 PHE 42 A PHE 43 n 43 PHE 43 A PHE 44 n 44 PHE 44 A ASN 45 n 45 ASN 45 A ILE 46 n 46 ILE 46 A PHE 47 n 47 PHE 47 A THR 48 n 48 THR 48 A ARG 49 n 49 ARG 49 A GLN 50 n 50 GLN 50 A CYS 51 n 51 CYS 51 A GLU 52 n 52 GLU 52 A GLU 53 n 53 GLU 53 A PHE 54 n 54 PHE 54 A ILE 55 n 55 ILE 55 A TYR 56 n 56 TYR 56 A GLY 57 n 57 GLY 57 A GLY 58 n 58 GLY 58 A CYS 59 n 59 CYS 59 A GLU 60 n 60 GLU 60 A GLY 61 n 61 GLY 61 A ASN 62 n 62 ASN 62 A GLN 63 n 63 GLN 63 A ASN 64 n 64 ASN 64 A ARG 65 n 65 ARG 65 A PHE 66 n 66 PHE 66 A GLU 67 n 67 GLU 67 A SER 68 n 68 SER 68 A LEU 69 n 69 LEU 69 A GLU 70 n 70 GLU 70 A GLU 71 n 71 GLU 71 A CYS 72 n 72 CYS 72 A LYS 73 n 73 LYS 73 A LYS 74 n 74 LYS 74 A MET 75 n 75 MET 75 A CYS 76 n 76 CYS 76 A THR 77 n 77 THR 77 A ARG 78 n 78 ARG 78 A ASP 79 n 79 ASP 79 A n 1 1 B n 2 2 B n 3 3 B n 4 4 B n 5 5 B n 6 6 B n 7 7 B n 8 8 B n 9 9 B n 10 10 B n 11 11 B n 12 12 B n 13 13 B n 14 14 B GLU 15 n 15 GLU 15 B LEU 16 n 16 LEU 16 B PRO 17 n 17 PRO 17 B PRO 18 n 18 PRO 18 B LEU 19 n 19 LEU 19 B LYS 20 n 20 LYS 20 B LEU 21 n 21 LEU 21 B MET 22 n 22 MET 22 B HIS 23 n 23 HIS 23 B SER 24 n 24 SER 24 B PHE 25 n 25 PHE 25 B CYS 26 n 26 CYS 26 B ALA 27 n 27 ALA 27 B PHE 28 n 28 PHE 28 B LYS 29 n 29 LYS 29 B ALA 30 n 30 ALA 30 B ASP 31 n 31 ASP 31 B ASP 32 n 32 ASP 32 B GLY 33 n 33 GLY 33 B PRO 34 n 34 PRO 34 B CYS 35 n 35 CYS 35 B LYS 36 n 36 LYS 36 B ALA 37 n 37 ALA 37 B ILE 38 n 38 ILE 38 B MET 39 n 39 MET 39 B LYS 40 n 40 LYS 40 B ARG 41 n 41 ARG 41 B PHE 42 n 42 PHE 42 B PHE 43 n 43 PHE 43 B PHE 44 n 44 PHE 44 B ASN 45 n 45 ASN 45 B ILE 46 n 46 ILE 46 B PHE 47 n 47 PHE 47 B THR 48 n 48 THR 48 B ARG 49 n 49 ARG 49 B GLN 50 n 50 GLN 50 B CYS 51 n 51 CYS 51 B GLU 52 n 52 GLU 52 B GLU 53 n 53 GLU 53 B PHE 54 n 54 PHE 54 B ILE 55 n 55 ILE 55 B TYR 56 n 56 TYR 56 B GLY 57 n 57 GLY 57 B GLY 58 n 58 GLY 58 B CYS 59 n 59 CYS 59 B GLU 60 n 60 GLU 60 B GLY 61 n 61 GLY 61 B ASN 62 n 62 ASN 62 B GLN 63 n 63 GLN 63 B ASN 64 n 64 ASN 64 B ARG 65 n 65 ARG 65 B PHE 66 n 66 PHE 66 B GLU 67 n 67 GLU 67 B SER 68 n 68 SER 68 B LEU 69 n 69 LEU 69 B GLU 70 n 70 GLU 70 B GLU 71 n 71 GLU 71 B CYS 72 n 72 CYS 72 B LYS 73 n 73 LYS 73 B LYS 74 n 74 LYS 74 B MET 75 n 75 MET 75 B CYS 76 n 76 CYS 76 B THR 77 n 77 THR 77 B ARG 78 n 78 ARG 78 B ASP 79 n 79 ASP 79 B ACE 0 n 1 ACE 0 C PHE 1 n 2 PHE 1 C GLN 2 n 3 GLN 2 C SER 3 n 4 SER 3 C LYS 4 n 5 LYS 4 C PRO 5 n 6 PRO 5 C ASN 6 n 7 ASN 6 C VAL 7 n 8 VAL 7 C HIS 8 n 9 HIS 8 C VAL 9 n 10 VAL 9 C ASP 10 n 11 ASP 10 C GLY 11 n 12 GLY 11 C TYR 12 n 13 TYR 12 C PHE 13 n 14 PHE 13 C GLU 14 n 15 GLU 14 C ARG 15 n 16 ARG 15 C LEU 16 n 17 LEU 16 C AIB 17 n 18 AIB 17 C ALA 18 n 19 ALA 18 C LYS 19 n 20 LYS 19 C LEU 20 n 21 LEU 20 C ACE 0 n 1 ACE 0 D PHE 1 n 2 PHE 1 D GLN 2 n 3 GLN 2 D SER 3 n 4 SER 3 D LYS 4 n 5 LYS 4 D PRO 5 n 6 PRO 5 D ASN 6 n 7 ASN 6 D VAL 7 n 8 VAL 7 D HIS 8 n 9 HIS 8 D VAL 9 n 10 VAL 9 D ASP 10 n 11 ASP 10 D GLY 11 n 12 GLY 11 D TYR 12 n 13 TYR 12 D PHE 13 n 14 PHE 13 D GLU 14 n 15 GLU 14 D ARG 15 n 16 ARG 15 D LEU 16 n 17 LEU 16 D AIB 17 n 18 AIB 17 D ALA 18 n 19 ALA 18 D LYS 19 n 20 LYS 19 D LEU 20 n 21 LEU 20 D 6.0311 -2.5206 2.3228 6.0316 -1.8818 4.7404 -0.2079 -0.1771 0.8764 0.0217 0.0096 -0.0810 -0.8999 -0.5480 0.1983 0.2262 0.1323 0.0422 0.1216 -0.0305 0.3969 refined -13.6806 -16.2708 9.9339 X-RAY DIFFRACTION 7.0881 -3.5234 1.1493 7.6496 -0.8403 4.8966 0.0695 -0.1288 -0.7769 -0.0641 0.1257 0.2331 0.8170 0.4608 -0.1953 0.1657 0.0966 0.0243 0.1124 0.0010 0.2601 refined 14.8306 -41.8889 4.6813 X-RAY DIFFRACTION 0.1600 -0.1140 1.0876 2.0262 -1.8376 8.3060 -0.0279 -0.2095 -0.0183 0.1261 0.2971 0.3653 -0.3724 -1.3738 -0.2692 0.1363 0.0205 0.0423 0.3466 0.0239 0.4034 refined -15.6987 -25.4721 18.4789 X-RAY DIFFRACTION 12.9509 -8.6428 -2.9321 10.4820 1.0800 0.8376 -0.2456 -0.5212 0.3030 0.4955 0.3052 -0.2255 0.0036 0.1765 -0.0595 0.0928 0.0666 -0.0012 0.2692 -0.0251 0.1788 refined 15.8854 -32.0454 12.2564 X-RAY DIFFRACTION A 2 A 79 X-RAY DIFFRACTION 1 B 15 B 79 X-RAY DIFFRACTION 2 C 0 C 20 X-RAY DIFFRACTION 3 D 0 D 20 X-RAY DIFFRACTION 4 author_and_software_defined_assembly PISA 2 dimeric author_and_software_defined_assembly PISA 2 dimeric 1920 -10.5 6190 2240 -10.2 5590 C AIB 17 ALPHA-AMINOISOBUTYRIC ACID C AIB 18 ALA D AIB 17 ALPHA-AMINOISOBUTYRIC ACID D AIB 18 ALA 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 x,y,z identity operation 0.0000000000 0.0000000000 0.0000000000 A N ILE 10 A N ILE 10 A O GLU 4 A O GLU 4 A N ASP 5 A N ASP 5 A O LEU 19 A O LEU 19 A N ASN 45 A N ASN 45 A O GLN 50 A O GLN 50 B N ASN 45 B N ASN 45 B O GLN 50 B O GLN 50 1 A HOH 2006 G HOH 1 C HOH 2008 I HOH 1 A ASP 1 A ASP 1 1 Y 1 B ASP 1 B ASP 1 1 Y 1 B SER 2 B SER 2 1 Y 1 B GLU 3 B GLU 3 1 Y 1 B GLU 4 B GLU 4 1 Y 1 B ASP 5 B ASP 5 1 Y 1 B GLU 6 B GLU 6 1 Y 1 B GLU 7 B GLU 7 1 Y 1 B HIS 8 B HIS 8 1 Y 1 B THR 9 B THR 9 1 Y 1 B ILE 10 B ILE 10 1 Y 1 B ILE 11 B ILE 11 1 Y 1 B THR 12 B THR 12 1 Y 1 B ASP 13 B ASP 13 1 Y 1 B THR 14 B THR 14 1 Y 1 C CA PRO 5 WRONG HAND 1 D CA PRO 5 WRONG HAND 1 B B O CA ARG ASP 78 79 0.90 1 B B O N ARG ASP 78 79 0.93 1 B B C CA ARG ASP 78 79 1.49 1 A A CA N ARG ASP 78 79 1.56 1 B B CA N ARG ASP 78 79 1.66 1 A A N O SER THR 2 14 1.74 1 A A O O GLU HOH 7 2003 2.18 1 A ARG 78 20.47 1 B ARG 78 -74.70 1 A A THR ASP 12 13 -143.64 1 B B C N ARG ASP 78 79 0.72 1 C C C N ACE PHE 0 1 2.46 1 D D C N ACE PHE 0 1 3.21 1 -52.75 2.20 117.20 64.45 A A A CA C N ARG ARG ASP 78 78 79 Y 1 13.71 1.60 122.70 136.41 A A A O C N ARG ARG ASP 78 78 79 Y 1 -29.73 2.50 121.70 91.97 A A A C N CA ARG ASP ASP 78 79 79 Y 1 -30.34 2.20 117.20 86.86 B B B CA C N ARG ARG ASP 78 78 79 Y 1 -74.30 1.60 122.70 48.40 B B B O C N ARG ARG ASP 78 78 79 Y 1 -44.27 2.50 121.70 77.43 B B B C N CA ARG ASP ASP 78 79 79 Y 1 B B C N ARG ASP 78 79 -0.617 0.023 1.336 0.719 Y 1 A GLU 6 -133.43 -59.07 1 A GLU 7 -138.90 -53.60 1 A PRO 17 -30.39 130.28 1 A GLU 60 59.93 -142.21 1 A ARG 65 -160.24 117.08 1 B GLU 60 58.30 -140.28 1 C AIB 17 -11.77 -65.61 1 D AIB 17 -11.32 -66.62 40.516 -0.82 0.00 -1.60 5.20 0.00 -4.27 0.903 0.855 HYDROGENS HAVE BEEN ADDED IN THE RIDING POSITIONS. U VALUES WITH TLS ADDED 0.26207 0.22664 0.22830 2.48 42.35 514 10318 4.7 92.45 17.820 0.196 RANDOM 1 THROUGHOUT OTHER 0.367 0.265 0.80 0.80 1.20 NONE MAXIMUM LIKELIHOOD MASK 2.48 42.35 72 1591 12 0 1507 0.010 0.019 1536 0.002 0.020 1446 1.845 1.968 2051 2.126 3.007 3326 7.916 5.000 177 32.874 23.951 81 18.411 15.000 279 16.301 15.000 10 0.523 0.200 204 0.005 0.021 1709 0.004 0.020 375 1 A 1 3439 X-RAY DIFFRACTION interatomic distance 0.09 0.05 2 B 1 3439 X-RAY DIFFRACTION interatomic distance 0.09 0.05 1 C 2 959 X-RAY DIFFRACTION interatomic distance 0.14 0.05 2 D 2 959 X-RAY DIFFRACTION interatomic distance 0.14 0.05 0.329 0.305 2.546 29 692 20 86.04 2.45 20.00 4BQD 12168 2.0 0.12 1 2.5 100.0 refinement REFMAC 5.7.0029 TISSUE FACTOR PATHWAY INHIBITOR (LIPOPROTEIN-ASSOCIATED COAGULATION INHIBITOR) VARIANT, PEPTIDE KD1 of human TFPI in complex with a synthetic peptide 1 N N 1 N N 2 N N 2 N N 3 N N 3 N N 4 N N 4 N N 4 N N 4 N N A HIS 23 A HIS 23 HELX_P A PHE 28 A PHE 28 5 1 6 A SER 68 A SER 68 HELX_P A THR 77 A THR 77 1 2 10 B HIS 23 B HIS 23 HELX_P B PHE 28 B PHE 28 5 3 6 B SER 68 B SER 68 HELX_P B THR 77 B THR 77 1 4 10 C GLY 11 C GLY 12 HELX_P C LEU 20 C LEU 21 1 5 10 D GLY 11 D GLY 12 HELX_P D LEU 20 D LEU 21 1 6 10 disulf 2.043 A CYS 26 A SG CYS 26 1_555 A CYS 76 A SG CYS 76 1_555 disulf 2.075 A CYS 35 A SG CYS 35 1_555 A CYS 59 A SG CYS 59 1_555 disulf 2.067 A CYS 51 A SG CYS 51 1_555 A CYS 72 A SG CYS 72 1_555 disulf 2.059 B CYS 26 B SG CYS 26 1_555 B CYS 76 B SG CYS 76 1_555 disulf 2.060 B CYS 35 B SG CYS 35 1_555 B CYS 59 B SG CYS 59 1_555 disulf 2.058 B CYS 51 B SG CYS 51 1_555 B CYS 72 B SG CYS 72 1_555 covale 1.330 both C LEU 16 C C LEU 17 1_555 C AIB 17 C N AIB 18 1_555 covale 1.327 both C AIB 17 C C AIB 18 1_555 C ALA 18 C N ALA 19 1_555 covale 1.330 both D LEU 16 D C LEU 17 1_555 D AIB 17 D N AIB 18 1_555 covale 1.324 both D AIB 17 D C AIB 18 1_555 D ALA 18 D N ALA 19 1_555 BLOOD CLOTTING BLOOD CLOTTING A B C D A 15 A 78 0 B 15 B 78 0 C 1 C 20 0 D 1 D 20 0 Q59EE5_HUMAN UNP 1 Q59EE5 4BQD PDB 2 4BQD 40 118 4BQD 1 79 Q59EE5 A 1 1 79 40 118 4BQD 1 79 Q59EE5 B 1 1 79 0 20 4BQD 0 20 4BQD C 2 1 21 0 20 4BQD 0 20 4BQD D 2 1 21 3 2 2 anti-parallel parallel anti-parallel anti-parallel A THR 9 A THR 9 A ILE 11 A ILE 11 A GLU 3 A GLU 3 A ASP 5 A ASP 5 A LEU 19 A LEU 19 A LYS 20 A LYS 20 A MET 39 A MET 39 A ASN 45 A ASN 45 A GLN 50 A GLN 50 A TYR 56 A TYR 56 B MET 39 B MET 39 B ASN 45 B ASN 45 B GLN 50 B GLN 50 B TYR 56 B TYR 56 BINDING SITE FOR RESIDUE GOL B 1080 Software 5 BINDING SITE FOR RESIDUE GOL B 1081 Software 4 B ASP 31 B ASP 31 5 1_555 B GLY 33 B GLY 33 5 1_555 B PRO 34 B PRO 34 5 1_555 B HOH 2025 H HOH 5 1_555 D ARG 15 D ARG 16 5 1_555 A MET 39 A MET 39 4 1_555 C AIB 17 C AIB 18 4 2_556 C LEU 20 C LEU 21 4 2_556 D LEU 20 D LEU 21 4 1_555 5 C 1 2 1